These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9164897)

  • 21. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Verapamil sustained-release in renal parenchymal hypertension: effect on blood pressure, kidney function, angiotensin II, aldosterone, arginine vasopressin, atrial natriuretic peptide, and lipoproteins.
    Eiskjaer H; Pedersen EB; Rasmussen LM; Jespersen B
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S17-22. PubMed ID: 2475677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of the antihypertensive efficacy and safety of using sustained release verapamil in elderly subjects using ambulatory blood pressure monitoring].
    Jasiński T; Janicki K; Klima M; Pieniazek W; Bednarz S
    Przegl Lek; 1996; 53(2):73-7. PubMed ID: 8754325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evening vs morning isradipine sustained release in essential hypertension: a double-blind study with 24 h ambulatory monitoring.
    Fogari R; Malacco E; Tettamanti F; Gnemmi AE; Milani M
    Br J Clin Pharmacol; 1993 Jan; 35(1):51-4. PubMed ID: 8448068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of controlled-onset extended-release verapamil on nocturnal blood pressure (dippers versus nondippers). COER-Verapamil Study Group.
    White WB; Mehrotra DV; Black HR; Fakouhi TD
    Am J Cardiol; 1997 Aug; 80(4):469-74. PubMed ID: 9285660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. Verapamil versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
    BMJ; 1989 Oct; 299(6704):881-6. PubMed ID: 2510877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of sustained-release verapamil therapy on the blood pressure at rest and on the pressor response to isometric exertion in hypertensive patients.
    Cardillo C; Musumeci V; Savi L; Guardigli R; Mores N; Folli G
    Eur J Clin Pharmacol; 1988; 34(6):549-53. PubMed ID: 3169108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of isolated systolic hypertension in the elderly with verapamil slow-release 240 mg.
    Böhmer F; Barousch R; Reinfrank J
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S45-6. PubMed ID: 2475685
    [No Abstract]   [Full Text] [Related]  

  • 30. A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning.
    Smith DH; Neutel JM; Weber MA
    Am J Hypertens; 2001 Jan; 14(1):14-9. PubMed ID: 11206672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effects of slow-release verapamil in relation to plasma concentration in aged hypertensives. A study with continuous monitoring of arterial pressure and electrocardiogram].
    Canonico V; Bonaduce D; De Caprio L; Nicolino A; Forgione L; Petretta M; Rengo F
    G Ital Cardiol; 1990 Oct; 20(10):924-32. PubMed ID: 2090531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of nadolol on hemodynamic and hemostatic responses to potential mental and physical triggers of myocardial infarction in subjects with mild systemic hypertension.
    Jimenez AH; Tofler GH; Chen X; Stubbs ME; Solomon HS; Muller JE
    Am J Cardiol; 1993 Jul; 72(1):47-52. PubMed ID: 8517427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy, safety and pharmacokinetics of verapamil SR vs verapamil IR in hypertensive patients.
    Fuenmayor NT; Faggin BM; Cubeddu LX
    Drugs; 1992; 44 Suppl 1():1-11. PubMed ID: 1283570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of slow-release verapamil and nitrendipine on office and 24-hour ambulatory blood pressure in hypertensive patients.
    Pannarale G; Puddu PE; Campbell SV; Collauto F; Stazi F; Reale A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 2():S53-6. PubMed ID: 1377307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of verapamil on home self-measurement of blood pressure and heart rate by hypertensive patients. Verapamil-Frequency Research Group.
    Fernández-González R; Gómez-Pajuelo C; Gabriel R; de La Figuera M; Moreno E; of The Verapamil-Frequency Res
    Blood Press Monit; 2000 Feb; 5(1):23-30. PubMed ID: 10804447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of COER-verapamil on circadian pattern of forearm vascular resistance and blood pressure.
    Nguyen BN; Parker RB; Noujedehi M; Sullivan JM; Johnson JA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1480-7. PubMed ID: 11185670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of slow-release verapamil on blood pressure and cardiovascular system in essential hypertension.
    Meric M; Adalet K; Erzengin F; Korkut F; Okur O; Büyüköztürk K
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S42-4. PubMed ID: 2475684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained release verapamil in hypertension. Results from a noninvasive ambulatory blood pressure monitoring and a clinical study.
    Nissinen A; Koistinen A; Tuomilehto J; Sundberg S; Gordin A
    Eur J Clin Pharmacol; 1986; 31(3):255-9. PubMed ID: 3539623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of sustained-release verapamil: automatic ambulatory blood pressure monitoring.
    Zachariah PK; Sheps SG; Schriger A
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):133S-142S. PubMed ID: 3540223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Instant and sustained-release verapamil in the treatment of essential hypertension.
    Midtbø K; Hals O; van der Meer J; Storstein L; Lauve O
    Am J Cardiol; 1986 Feb; 57(7):59D-63D. PubMed ID: 3513516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.